Nvidia's $25bn seven-tranche offering matched Meta’s issuance in late April which are only smaller than Amazon’s $37bn print from March

Bond market's leading performers recognised at GlobalCapital's annual awards ceremony

The Hong Kong dollar bond market is evolving beyond being one exclusively of private placements to one where public issuance of varying sizes and maturities is becoming more common. The greater frequency of public issuance is leading to more opportunities for investors and issuers alike. Sustaining this growth will require a bigger variety of asset classes, and more diversified local and international participation. GlobalCapital assembled a group of investors and issuers from across the bond market to discuss this burgeoning market and the progress they want to see from it in the future.

◆ Anglian Water finds attractive pricing in euros ◆ Iberdrola pays small NIP on dual tranche EuGB ◆ Statnett and EEW Energy bring single tranche green deals

PKO is the fourth Polish bank to debut in the tier two market in the last year

◆ Island region prices €500m sustainable 10 year ◆ Spread tightened 5bp from guidance after book grew ◆ Banker away from deal sees no congestion drag

Hybrid capital is open to the big US tech companies. But who needs an umbrella when the sun is shining?

The bank has been added to DNB's list of registered covered bond issuers

Issuance will be lower in June as yields rise

Amazon’s Swiss debut and Alphabet’s first yen deal jolted debt markets this week

Artificial intelligence is changing the investment banking game. But banks are divided on whether to cut costs or try and win more deals

The US bank is showing its global credentials at a time of increased transatlantic tensions but European banks are equal to the challenge

Five year bond set to be priced much tighter than the development bank's last senior issue

International Finance Corp’s drive to introduce development finance to the CLO market is advancing. Its second deal of $509m had more investors, more tranches and better pricing, supporting its rapid growth

Investors were eager to tender their bonds despite initial resistance

Increased investor interest in utilities hybrids could bring down subordination premium, says SSE treasurer

Divisions deepen over multilateral development banks’ climate commitments

◆ UK utility prints €1.3bn dual trancher ◆ Issuer skips guidance as it masses orders north of €10bn ◆ Longer call leg draws stronger demand

Investors were impressed with how the region's issuers have dealt with the crisis

Book coverage ratio was in the same area as Gulf banks' pre-Iran war euro issuance

Bankers eye Warsh's debut, private credit and stretched equity valuations

Commercial real estate has been one of the hardest hit sectors during the Covid-19 pandemic. The images of shuttered shops and empty offices are almost as emblematic of the Covid crisis as facemasks and stay-at-home warnings. Although there is hope for a recovery in issuance led by the red-hot growth in logistics sites, the outlook is uncertain given that underlying values of many properties backing existing CMBS remain unknown. Sam Kerr reports.

In mid-May GlobalCapital convened representatives of three RMBS issuers with different business models and approaches for a wide-ranging discussion about the state of the UK mortgage markets, funding strategies, and much more. Kensington is the most frequent issuer in European RMBS, with a track record stretching back to 1995, and more than £10bn of assets under management, including about £6bn of servicing mandates. LendInvest and Habito are fintech lenders, with LendInvest originating bridging loans and buy-to-let, funded through securitizations (LendInvest has completed two public deals so far), retail bonds, funds, and private capital, including a £500m partnership with JP Morgan. Habito mixes technology-enabled mortgage broking with its own buy-to-let originations, funded through Citi’s securitization shelf, and has recently launched the first long-term (up to 40 years) fixed rate mortgage product in the UK, funded through a partnership with CarVal Investors.

AstraZeneca, the UK drug company, showed the eager demand for merger and acquisition financings this week when it achieved ultra-tight pricing on a $7bn bond issue to fund its acquisition of US biotech firm Alexion Pharmaceuticals.